<DOC>
	<DOCNO>NCT01431924</DOCNO>
	<brief_summary>This observational retrospective analysis link pharmacy medical claim data IMS Health/Pharmetrics database . comprehensive , de-identified United States ( US ) healthcare claim database representative non-elderly , insurance-carrying population , The total population 35.4 million . The average length follow-up 2.7 year mean ( 2.2 year median ) . Subjects identified database least one ICD-9 diagnostic code ( 493.xx ) asthma least 1 asthma treatment within 12-month period prior index use fluticsasone propionate/salmeterol xinafoate inhale corticosteroid . Subjects follow database event interest ( asthma-related emergency department visit , hospitalization , oral corticosteroid use combination asthma-related emergency department/hospitalization asthma-related emergency department/hospitalization/oral corticosteroid ) lose follow whichever come first . Subjects censor leave database , event interest , dispense another asthma controller medication interest . All outcome assess follow-up period . Time-dependent statistical model adjust difference baseline ( pre-index ) asthma patient demographic use compare asthma event .</brief_summary>
	<brief_title>Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate Inhaled Corticosteroids Asthma Patients</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>One medical claim diagnosis ( primary secondary ) asthma ( ICD9CM 493.XX ) study period ; One outpatient pharmacy claim study one follow `` study medication '' : Fluticasone propionate/salmeterol xinafoate 250 mcg/50 mcg 100mcg/50mcg combination Fluticasone propionate 110 mcg 220 mcg One asthma exacerbation ( asthmarelated hospitalization emergency department visit , oral corticosteriod prescription drug claim , combination event ) 12 month prior index date ( `` preindex period '' ) Five prescription shortacting beta agonist preindex period . Patients one study medication 3month period begin index date ; One prescription within three month index date ( pre post ) ICS LABA study medication One prescription within three month post index date : Any asthma maintenance medication Any medical claim study period diagnosis : Chronic obstructive pulmonary disease ( COPD ) ( ICD9CM 491 , 492 , 496 ) ; Respiratory tract cancer ( ICD9CM 160164 , 231 )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>outcome</keyword>
	<keyword>observational</keyword>
	<keyword>retrospective</keyword>
	<keyword>database</keyword>
	<keyword>asthma</keyword>
</DOC>